The BIOKÉ webshop is under construction until January 2nd, 2018. We wish you a successful 2018!
Founded in 2002, ACEA Biosciences, Inc. is a privately owned biotechnology company that is pioneering the development and commercialization of high performance, cutting edge cell analysis instruments for life science research and clinical diagnostics. ACEA Biosciences’ mission is to provide innovative high performance technologies that advance scientific discovery and improve healthcare.
ACEA products are used by researchers across the globe for drug discovery and development, toxicology, flow cytometry, safety pharmacology, disease studies, clinical diagnostics, and basic research.
Employing noninvasive impedance microelectrodes in automated high-throughput plate formats, our xCELLigence®Real-Time Cell Analysis (RTCA) instruments maximize the physiological relevance of data extracted from in vitro cellular assays. These instruments enable label-free, real-time monitoring of cell proliferation, cell size/morphology, cell-substrate attachment quality, and cell invasion/migration. By eliminating the time- and labor-intensive steps of traditional methods, RTCA vastly improves efficiency and overall productivity. Moreover, the flexibility, sensitivity, and reproducibility of RTCA make it a standout amongst cell-based assay platforms.
ACEA is also helping to revolutionize the field of flow cytometry by designing and producing high performance, customizable benchtop cytometers at accessible price points. By including features such as 13 fluorescence detection channels with 3 lasers, direct volumetric based cell counting, and a versatile high throughput walkaway autosampler, ACEA’s line of NovoCyte™ flow cytometers is raising the bar for what is expected of benchtop machines.
With 4 lasers, 25 colors, and 25 independent, highly sensitive detectors, the new NovoCyte Quanteon™ easily accommodates the large, multi-color panels found in today’s highly progressive flow cytometry laboratories. Yet, with a number of key features such as auto compensation, as well as fixed and flexible signal collection options, the system is remarkably easy to set up for users of all levels and experience.
xCELLigence® and NovoCyte™ instruments are currently being used worldwide in academic, industrial, and hospital labs for preclinical drug discovery and development, toxicology, safety pharmacology, disease studies, clinical diagnostics, and basic research.
BIOKÉ is the exclusive distributor of the NovoCyte benchtop flow cytometer and xCELLigence RTCA Systems from ACEA Biosciences in The Netherlands, Belgium and Luxembourg.